2nd Quarter - Report
THORN RUN PARTNERS for NOVO NORDISK INC.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.309, National Clinical Care Commission Act. General healthcare including issues related to diabetes and hemophilia. S.830/H.R.1953, A bill to amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes; issues related to coverage and reimbursement of obesity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| MICHAEL O'SHEA MCCARTHY | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (ULTIMATE PARENT COMPANY) | Denmark | Denmark | 100.0% | — |
| CLIENT IS A WHOLLY-OWNED SUBSIDIARY OF NOVO NORDISK US WHICH IS WHOLLY-OWNED BY NOVO NORDISK A/S. | Denmark | Denmark | 100.0% | — |
| NOVO A/S (OWNS 26.5% OF NN A/S) | Denmark | Denmark | 26.5% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.